XML 54 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Organization and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Changes in Estimated Product Warranty Liabilities
Changes in our estimated warranty reserve were as follows (in thousands):
 
2019
 
2018
 
2017
Balance, January 1
$
898

 
$
644

 
$
780

Utilization of reserve
(973
)
 
(458
)
 
(245
)
Warranty expense
1,551

 
712

 
109

Balance, December 31
$
1,476

 
$
898

 
$
644


Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Additional assumptions used for the CEO Performance Award and the resulting estimates of weighted-average fair value per share of options granted are as follows:
Volatility
 
47.71%
Risk-free interest rate
 
2.98%
Dividend rate
 
Expected life of options
 
9.76 years
Weighted average grant date fair value of options granted
 
$38.64

Schedule of Weighted Average Number of Shares Outstanding and Income Per Share The calculation of the weighted average number of shares outstanding and earnings per share are as follows (in thousands except per share data):
 
For the Year Ended December 31,
 
2019
 
2018
 
2017
Numerator for basic and diluted earnings per share:
 
 
 
 
 
Net income
$
882

 
$
29,205

 
$
5,207

Denominator:
 
 
 
 
 
Weighted average shares outstanding—basic
59,190

 
56,392

 
52,726

Dilutive effect of stock-based awards
828

 
1,530

 
1,172

Diluted weighted average shares outstanding
60,018

 
57,922

 
53,898

Anti-dilutive stock-based awards excluded
12,627

 
6,757

 
386

Net income per common share:
 
 
 
 
 
Basic
$
0.01

 
$
0.52

 
$
0.10

Diluted
$
0.01

 
$
0.50

 
$
0.10


Schedule of Adjustments to Opening Balance Sheet There was no other impact from the adoption. The adjustments to the opening balance sheet were as follows (in thousands):
 
December 31, 2018
 
Impact of Adoption of Topic 842 on Opening Balance Sheet
 
January 1, 2019
 
(As reported)
 
 
(As adjusted)
Consolidated Balance Sheet Data:
 
 
 
 
 
Other assets
$
22,999

 
$
12,483

 
$
35,482

Total assets
719,540

 
12,483

 
732,023

 
 
 
 
 
 
Accrued liabilities
41,092

 
(1,138
)
 
39,954

Other current liabilities
37

 
3,588

 
3,625

Total current liabilities
166,011

 
2,450

 
168,461

Other long-term liabilities
5,704

 
10,033

 
15,737

Total liabilities
252,216

 
12,483

 
264,699

Total liabilities and stockholders' equity
719,540

 
12,483

 
732,023